Products

Sandoo magnum est Ketorolac Trometamolum, Hydrochloridum Olopatadinum, Vancomycin hydrochloridum artifices et praebitores in Sinis. Nostra officina in API, anti-cancro, antivirali medicamento media, subtilia chemicis, cibariis additivis export et plus quam X annos importat, positi sunt, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniae Regnum. Gallia, etc., et paulatim plus XX regionibus circum orbem terrarum tegunt.
View as  
 
7-bromo-2,4,8,9-tetrazabicyclo [4.3.0]nona-2,4,6,9-tetraen-5-amine

7-bromo-2,4,8,9-tetrazabicyclo [4.3.0]nona-2,4,6,9-tetraen-5-amine

Product Name:7-bromo-2,4,8,9-tetrazabicyclo[4.3.0]nona-2,4,6,9-tetraen-5-amine
Formulae hypotheticae: C5H4BrN5
Molecular Weight:214.02
CAS Registry Number: 83255-86-1

Lege plusMitte Inquisitionem
Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-

Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-

Product Name:Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-
Formulae hypotheticae: C17H12N2O2
Molecular Weight:276.29
CAS Registry Number: 330792-69-3

Lege plusMitte Inquisitionem
4-Aminopyrazolo[3,4-d]pyrimidine

4-Aminopyrazolo[3,4-d]pyrimidine

Product Name:4-Aminopyrazolo[3,4-d]pyrimidine
Formulae hypotheticae: C5H5N5
Molecular pondus:135.13
CAS Subcriptio Number:2380-63-4

Lege plusMitte Inquisitionem
(S)Ibr09A

(S)Ibr09A

Product Name:(S)Ibr09A
Formulae hypotheticae: C22H23ClN6O
Molecular Weight:422.92
CAS Subcriptio Number:203125-22-6

Lege plusMitte Inquisitionem
(R) -1-Boc-3-Hydroxypiperidine

(R) -1-Boc-3-Hydroxypiperidine

Product Name:(R)-1-Boc-3-Hydroxypiperidine
Formulae hypotheticae: C10H19NO3
Molecular pondus:201.26
CAS Subcriptio Number:143900-43-0

Lege plusMitte Inquisitionem
3-Nitrophthalic anhydride

3-Nitrophthalic anhydride

Product Name: 3-Nitrophthalic anhydride
Formulae hypotheticae: C8H3NO5
Molecular pondus:193.11
CAS Subcriptio Number:641-70-3

Lege plusMitte Inquisitionem
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept